View Article

  • A Study To Identify The Prevelance Of Covid 19 Vaccine Related Adverse Events Side Effects Among General Public In Dakshina Kannada

  • 1Department of Pharmacy Practice, Srinivas College of Pharmacy, Manglore-574143
    2Department of Pharmacy Practice, Srinivas College of Pharmacy, Manglore-574143
    3Department of Pharmaceutics, Srinivas College of Pharmacy, Manglore-574143
     

Abstract

The widespread distribution of COVID-19 vaccines has been a critical public health measure in mitigating the impact of the pandemic. Monitoring vaccine safety and understanding the prevalence of vaccine-related adverse events and side effects is essential for maintaining public trust and ensuring effective vaccination campaigns. This study was aimed to investigate the prevalence of adverse events and side effects associated with COVID-19 vaccinations among the general public in the Dakshina Kannada region. The data were gathered from a convenience sample of 1000 people each from the general public and pre-validated questionnaires were utilized to gather data. The study findings revealed a spectrum of adverse events and side effects reported by participants, ranging from mild local reactions to rare systemic effects. The prevalence and severity of adverse events varied between different vaccine types and age groups. The study concluded with the fact that about [77%] of respondents had adverse effects in which swelling at the site of injection; fever and headache where (35.9%). The participants were fearful of short-term adverse effects, uncertain about the decision, and confident in the initial doses, which is why they did not receive the booster dose in comparison to the other two doses. The severity of covid-19, as well as the side effects and efficacy of the vaccine, were the key factors that explained the likelihood of rejection or indecision. In conclusion this study provides valuable insights into the prevalence of COVID-19 vaccine-related adverse events and side effects in Dakshina Kannada. These findings can inform public health efforts, vaccination campaigns, and healthcare guidance to better address and manage adverse events, ultimately contributing to the continued success of COVID-19 vaccination programs.

Keywords

Covid- 19, Adverse drug reactions, Side effects

Reference

  1. A review of adverse effects of COVID-19 vaccines. Infezioni in Medicina. 2022; 30(1).
  2. Lai C.-C .Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int. J. Antimicrob. Agents,2020; 55:105-924.
  3. Thiagarajan K. Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust. BMJ. 2021; 196.
  4. Koritala T, Hussain A, Pleshkova Y, et al. A narrative review of emergency use authorization versus full FDA approval and its effect on COVID-19 vaccination hesitancy. Infez Med. 2021; 3:339–44.
  5.  Kimmel SR. Vaccine adverse events: separating myth from reality. Am Fam Physician. 2002; 66(11):2113–20.
  6. Mahapatra S, Nagpal R, Marya C, Taneja P, Kataria S. Adverse events occurring post-covid-19 vaccination among healthcare professionals – A mixed method study. International Immunopharmacology. 2021;100:108136.
  7. Gee, J.; Marquez, P.; Su, J.; Calvert, G.M.; Liu, R.; Myers, T.; Nair, N.; Martin, S.; Clark, T.; Markowitz, L.; et al. First Month of COVID-19 Vaccine Safety Monitoring-United States, December 14, 2020–January 13, 2021. Morb. Mortal. Wkly. Rep. 2021, 70, 283–88.
  8. Patone, M.; Handunnetthi, L.; Saatci, D.; Pan, J.; Katikireddi, S.V.; Razvi, S.; Hunt, D.; Mei, X.W.; Dixon, S.; Zaccardi, F.; et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 2021, 27, 2144–2153.
  9. Hause, A.M. Safety Monitoring of an Additional Dose of COVID-19 Vaccine—United States, 12 August–19 September 2021. Morb. Mortal. Wkly. Rep. 2021, 70, 1379.
  10. Barda, N.; Dagan, N.; Ben-Shlomo, Y.; Kepten, E.; Waxman, J.; Ohana, R.; Hernán, M.A.; Lipsitch, M.; Kohane, I.; Netzer, D.; et al. Safety of the BNT162b2 mRNA COVID-19 Vaccine in a Nationwide Setting. N. Engl. J. Med. 2021, 385, 1078–1090.
  11. Tenforde, M.W.; Olson, S.M.; Self, W.H.; Talbot, H.K.; Lindsell, C.J.; Steingrub, J.S. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ?65 Years-United States, January–March2021. Morb. Mortal. Wkly. Rep. 2021, 70, 674–679.
  12. Scobie, H.M.; Johnson, A.G.; Suthar, A.B.; Severson, R.; Alden, N.B.; Balter, S.; Bertolino, D.; Blythe, D.; Brady, S.; Cadwell, B.; et al. Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status—13 US jurisdictions, 4 April–17 July 2021. Morb. Mortal. Wkly. Rep. 2021, 70, 1284

Photo
Vilas Pai
Corresponding author

Department of Pharmacy Practice, Srinivas College of Pharmacy, Mangalore- 576143

Photo
SATISH S
Co-author

Department of Pharmacy Practice, Srinivas College of Pharmacy, Manglore-574143

Photo
RAMAKRISHNA SHABARAYA A
Co-author

Department of Pharmaceutics, Srinivas College of Pharmacy, Manglore-574143

Satish S, Vilas Pai*, Ramakrishna Shabaraya A, A Study To Identify The Prevelance Of Covid – 19 Vaccine Related Adverse Events/ Side- Effects Among General Public In Dakshina Kannada., 2023, Vol 1, Issue 11, 378-384. https://doi.org/10.5281/zenodo.10154149

More related articles
Pharmacovigilance and Over Counter Drugs Ensuring ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Pharmacovigilance and Over Counter Drugs Ensuring ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Review On Effectual Communication In Pharmacovigil...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
Review On Effectual Communication In Pharmacovigilance...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
Assessment and Pharmacovigilance of Drug-Drug Interactions in Hypertension: A Re...
Raja Waleed Sajjad, Huma Tanveer, Ahmad Nawaz, Saba Manzoor, Syeda Fatima Ashoor, Raja Ahmed, ...
Related Articles
Pharmacovigilance: Safeguarding Patients Through Drug Safety Monitoring ...
Bhushan Rajput , aditya yadav, Dikshita Madhavi, Neha harad, Tejaswini asawe, Pradnya pophale, ...
Doxycycline induced Urticaria: A Case Report...
Mitta Putta Pooja, Kiranmai Venkatagiri, Sandeep Reddy Ambati, Bhavya Sai Sakhamuri, Sai Keshava Red...
Pharmacovigilance and the Process of ADR reporting and Monitoring in India ...
Pratiksha Salunkhe , Sunil Yadav, Harshada Jadhav, Dr. Shoheb Shaikh, ...
An Overview of Thyroxine Drug and Its Application...
vikas sonur, Ayan Sayyad, Digvijay Dalvi, ...
Pharmacovigilance and Over Counter Drugs Ensuring Safety ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
More related articles
Pharmacovigilance and Over Counter Drugs Ensuring Safety ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Pharmacovigilance and Over Counter Drugs Ensuring Safety ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Review On Effectual Communication In Pharmacovigilance...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...
Pharmacovigilance and Over Counter Drugs Ensuring Safety ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Pharmacovigilance and Over Counter Drugs Ensuring Safety ...
Vrushali Gaikwad , Sonal Kumbhar , Dr.Nilesh B.chougule , ...
Review On Effectual Communication In Pharmacovigilance...
Suraj Kumar Prajapati , Tarkeshwar P. Shukla , Pramod Mishra , ...